AGL 39.70 Decreased By ▼ -0.43 (-1.07%)
AIRLINK 189.90 Increased By ▲ 0.47 (0.25%)
BOP 9.85 Decreased By ▼ -0.49 (-4.74%)
CNERGY 7.07 Decreased By ▼ -0.14 (-1.94%)
DCL 10.25 Increased By ▲ 0.04 (0.39%)
DFML 41.20 Decreased By ▼ -0.60 (-1.44%)
DGKC 106.06 Decreased By ▼ -2.57 (-2.37%)
FCCL 37.70 Decreased By ▼ -0.89 (-2.31%)
FFBL 93.68 Increased By ▲ 3.77 (4.19%)
FFL 14.99 Decreased By ▼ -0.03 (-0.2%)
HUBC 122.49 Decreased By ▼ -0.74 (-0.6%)
HUMNL 14.29 Decreased By ▼ -0.16 (-1.11%)
KEL 6.40 Increased By ▲ 0.06 (0.95%)
KOSM 8.11 Decreased By ▼ -0.29 (-3.45%)
MLCF 48.65 Decreased By ▼ -0.82 (-1.66%)
NBP 72.25 Decreased By ▼ -2.57 (-3.43%)
OGDC 224.00 Increased By ▲ 10.59 (4.96%)
PAEL 33.64 Increased By ▲ 0.65 (1.97%)
PIBTL 9.68 Increased By ▲ 0.61 (6.73%)
PPL 204.00 Increased By ▲ 4.07 (2.04%)
PRL 33.99 Decreased By ▼ -0.56 (-1.62%)
PTC 26.68 Decreased By ▼ -0.53 (-1.95%)
SEARL 116.85 Decreased By ▼ -1.34 (-1.13%)
TELE 9.66 Decreased By ▼ -0.22 (-2.23%)
TOMCL 36.60 Increased By ▲ 1.18 (3.33%)
TPLP 12.05 Decreased By ▼ -0.52 (-4.14%)
TREET 24.52 Increased By ▲ 2.23 (10%)
TRG 61.00 Increased By ▲ 0.10 (0.16%)
UNITY 35.75 Decreased By ▼ -0.94 (-2.56%)
WTL 1.78 Decreased By ▼ -0.01 (-0.56%)
BR100 12,150 Decreased By -15.1 (-0.12%)
BR30 38,093 Increased By 312.6 (0.83%)
KSE100 114,302 Increased By 121.3 (0.11%)
KSE30 35,805 Increased By 104.1 (0.29%)

KARACHI: As Pakistan’s pharmaceutical sector aims to leverage its potential for increased exports, industry experts are calling for government support to create an enabling environment for growth.

Key officials express that with the right policy framework, exports could rise dramatically from the current levels. Industry leaders pointed out that while sectors such as textiles, carpets, leather, sports goods, and surgical instruments receive preferential treatment, pharmaceuticals have not enjoyed similar benefits.

The current export facilitation framework appears to favour established sectors based on past performance, overlooking the substantial potential of pharmaceuticals, which could significantly contribute to foreign exchange inflows.

Pakistan Pharma Summit 2024: experts gather with aim to chart path for growth in pharmaceutical industry

Currently, Pakistan’s pharmaceutical industry has performed well in specific markets. Countries like Uzbekistan, Nigeria, and Afghanistan are among those where pharmaceuticals rank as major export commodities.

“Even based on existing performance, there are several countries where pharmaceutical products from Pakistan are the largest exported commodity,” underscoring the sector’s robust international footprint.

A former chairman of the Pakistan Pharmaceutical Manufacturers’ Association (PPMA) has already stated that the country’s pharmaceutical exports could reach $3 billion within the next five years if the government prioritises the sector in its export policies. In contrast, Indian pharmaceutical exports were projected to hit $28 billion, while Pakistan’s exports hit a historic high of just over $341 million in 2023-24.

Experts believed that a structured market development assistance (MDA) programme similar to India’s initiative could provide necessary support to local pharmaceutical companies.

Furthermore, they advocated for a thorough assessment of local API production capabilities before imposing duties, arguing that such measures can ensure affordability and competitiveness of Pakistani pharmaceutical products. The sector also faces challenges related to maintaining a stable supply chain and reliable raw material procurement, which are key to securing lasting agreements in foreign markets. As observed, foreign markets typically demand long-term contracts of up to seven years, creating a need for predictability in supply chains and procurement strategies.

With the government exploring avenues to generate foreign exchange and reduce dependency on debt, focusing on non-debt creating exports is critical. Analysts point out that despite significant rupee depreciation over recent years, the anticipated growth in exports has not materialized, suggesting that new strategies are necessary to unlock Pakistan’s export potential.

Copyright Business Recorder, 2024

Comments

Comments are closed.

Obaid Ali Nov 13, 2024 08:43pm
Functioning based on the incorrect hypothesis would be wrong. Don't be victim of ignorant. First and last word is Quality. No body ask anybody to manufacture poor quality drug. Be honest please
thumb_up Recommended (0)